Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial

BACKGROUND: The early use of broad-spectrum antibiotics remains the cornerstone for the treatment of neonatal late onset sepsis (LOS). However, which antibiotics should be used is still debatable, as relevant studies were conducted more than 20 years ago, recruited in single centres or countries, ev...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:PLoS One
المؤلفون الرئيسيون: Lutsar, Irja, Chazallon, Corine, Trafojer, Ursula, de Cabre, Vincent Meiffredy, Auriti, Cinzia, Bertaina, Chiara, Calo Carducci, Francesca Ippolita, Canpolat, Fuat Emre, Esposito, Susanna, Fournier, Isabelle, Hallik, Maarja, Heath, Paul T., Ilmoja, Mari-Liis, Iosifidis, Elias, Kuznetsova, Jelena, Meyer, Laurence, Metsvaht, Tuuli, Mitsiakos, George, Pana, Zoi Dorothea, Mosca, Fabio, Pugni, Lorenza, Roilides, Emmanuel, Rossi, Paolo, Sarafidis, Kosmas, Sanchez, Laura, Sharland, Michael, Usonis, Vytautas, Warris, Adilia, Aboulker, Jean-Pierre, Giaquinto, Carlo
التنسيق: Artigo
اللغة:Inglês
منشور في: Public Library of Science 2020
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055900/
https://ncbi.nlm.nih.gov/pubmed/32130261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229380
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة